Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZipLine Medical was a U.S. medical device company focused on non-invasive skin closure products for surgical incisions and lacerations. Its core commercial product line was the Zip surgical skin closure family, designed to provide suture-like wound approximation without skin puncture and with faster application than traditional sutures. The company positioned its technology around improved cosmesis, lower wound tension, and easier post-operative recovery. ZipLine Medical operated as a medtech company rather than a therapeutics developer, so it did not have a drug pipeline in the biotech sense. The company was acquired by Stryker in 2019, and the Zip skin closure product line continues under Stryker.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZipLine Medical.